His primary scientific interests are in Immunology, Virology, CD8, T cell and IL-2 receptor. His Immunology study combines topics from a wide range of disciplines, such as Orthopoxvirus and Modified vaccinia Ankara. His Virology study frequently draws connections to other fields, such as Antigen.
His CD8 research includes themes of Epitope, Interleukin-7 receptor, T lymphocyte and Major histocompatibility complex. His IL-2 receptor research integrates issues from Natural killer T cell, Interleukin 21 and Antigen-presenting cell. His Antigen-presenting cell research incorporates themes from MHC restriction and Antigen presentation.
John D. Altman spends much of his time researching Virology, CD8, T cell, Immunology and Interleukin 21. His studies in Virology integrate themes in fields like Epitope and CTL*. John D. Altman interconnects Molecular biology, Human leukocyte antigen, Major histocompatibility complex and Spleen in the investigation of issues within CD8.
The T cell study combines topics in areas such as Antigen and Cell biology. The Lymphocytic choriomeningitis, T lymphocyte and Lymphocyte research John D. Altman does as part of his general Immunology study is frequently linked to other disciplines of science, such as Population and Mycobacterium tuberculosis, therefore creating a link between diverse domains of science. His research investigates the connection with Interleukin 21 and areas like IL-2 receptor which intersect with concerns in Antigen-presenting cell, Natural killer T cell and Cancer research.
His primary areas of study are T cell, Cell biology, T-cell receptor, Antigen and CD1. His T cell research includes elements of CD8 and Virology. John D. Altman combines subjects such as Viral replication and Simian immunodeficiency virus with his study of CD8.
His T-cell receptor research incorporates elements of Antigen-presenting cell, Lipidomics, Molecular biology, Lipopeptide and Major histocompatibility complex. His Antigen study integrates concerns from other disciplines, such as Sequence motif, Peptide sequence and Sequence analysis. The CD1 study which covers Antigen presentation that intersects with Biochemistry.
T-cell receptor, T cell, Antigen, Antigen presentation and Biochemistry are his primary areas of study. As a member of one scientific family, John D. Altman mostly works in the field of T-cell receptor, focusing on Cell biology and, on occasion, Major histocompatibility complex, Receptor and CD1D. His work on Antigen-presenting cell and Antigen processing as part of general T cell study is frequently connected to Population, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His research in Antigen-presenting cell intersects with topics in Ex vivo, Interleukin 21 and Bacterial antigen. His study in the field of CD1 and MHC class I also crosses realms of Protein footprinting. His biological study spans a wide range of topics, including Immune system and Bacteria.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Phenotypic Analysis of Antigen-Specific T Lymphocytes
John D. Altman;Paul A. H. Moss;Philip J. R. Goulder;Dan H. Barouch.
Science (1996)
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Kaja Murali-Krishna;John D Altman;M Suresh;David J.D Sourdive.
Immunity (1998)
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Allan J. Zajac;Joseph N. Blattman;Kaja Murali-Krishna;David J.D. Sourdive.
Journal of Experimental Medicine (1998)
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
Rama Rao Amara;Francois Villinger;John D. Altman;Shari L. Lydy.
Science (2001)
Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.
Todd M. Allen;David H. O'Connor;Peicheng Jing;John L. Dzuris.
Nature (2000)
Persistence of Memory CD8 T Cells in MHC Class I-Deficient Mice
Kaja Murali-Krishna;Lisa L. Lau;Suryaprakash Sambhara;Francois Lemonnier.
Science (1999)
Virus-Specific CD8+ T Cells in Primary and Secondary Influenza Pneumonia
Kirsten J Flynn;Gabrielle T Belz;John D Altman;Rafi Ahmed.
Immunity (1998)
Estimating the Precursor Frequency of Naive Antigen-specific CD8 T Cells
Joseph N. Blattman;Rustom Antia;David J.D. Sourdive;Xiaochi Wang.
Journal of Experimental Medicine (2002)
Mouse CD94/NKG2A Is a Natural Killer Cell Receptor for the Nonclassical Major Histocompatibility Complex (MHC) Class I Molecule Qa-1b
Russell E. Vance;Jennifer R. Kraft;John D. Altman;Peter E. Jensen.
Journal of Experimental Medicine (1998)
Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines.
Joseph D. Miller;Robbert G. van der Most;Rama S. Akondy;John T. Glidewell.
Immunity (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Emory University
University of Wisconsin–Madison
Monash University
Erasmus University Rotterdam
Brigham and Women's Hospital
Ragon Institute of MGH, MIT and Harvard
University of Melbourne
La Jolla Institute For Allergy & Immunology
Careggi University Hospital
University of Queensland
Google (United States)
University of Erlangen-Nuremberg
Chimie ParisTech
Vanderbilt University
University of Manchester
University of Missouri
Max Planck Society
Columbia University
Goddard Space Flight Center
Deakin University
Stetson University
Newcastle University
University of Santiago de Compostela
Max Planck Society
Fermilab